Allelix Regains Osteoporosis Drug ALX1-11, Casualty Of Astra-Merck Breakup
Executive Summary
Allelix Biopharmaceuticals has reacquired full rights to its Phase II osteoporosis drug ALX1-11 (recombinant human parathyroid hormone) from Astra AB after development of the compound stalled at Astra for over a year.